Apuzzio J J, Reyelt C, Pelosi M, Sen P, Louria D B
Obstet Gynecol. 1982 Jun;59(6):693-8.
The efficacy of ticarcillin in the prevention of post-cesarean section endomyometritis was studied in 259 women randomly given either the antibiotic or a placebo. The ticarcillin group received 6 g intravenously immediately after delivery. Then 22 of those patients were also given a second 3-g dose 6 to 8 hours after delivery. Among the 139 patients who received ticarcillin, endomyometritis developed in 44 (32%), as it did in 66 of 120 patients (55%) in the placebo group. These differences are highly significant (P = .002). Of the 259 patients in the study, 238 could be classified as to risk for endomyometritis developing. Among the 124 high-risk patients, 52 received a placebo and endomyometritis developed in 71%. Only 26 of the 72 high-risk patients who received ticarcillin (36%) were so infected. Among the low-risk patients, endomyometritis developed in 10 of 54 patients (18.5%) who received prophylaxis and in 24 of 60 patients who received placebo (40%). Ticarcillin appears to be effective in reducing the incidence of post-cesarean section endomyometritis in patients at high risk and in those at low risk. The number of pelvic examinations during labor was the most important single factor in the development of endomyometritis.
在259名随机接受抗生素或安慰剂的女性中,研究了替卡西林预防剖宫产术后子宫内膜炎的疗效。替卡西林组在分娩后立即静脉注射6克。然后,其中22名患者在分娩后6至8小时还接受了第二次3克剂量的注射。在接受替卡西林的139名患者中,44名(32%)发生了子宫内膜炎,而安慰剂组120名患者中有66名(55%)发生了子宫内膜炎。这些差异具有高度显著性(P = 0.002)。在该研究的259名患者中,238名可根据发生子宫内膜炎的风险进行分类。在124名高危患者中,52名接受了安慰剂,71%发生了子宫内膜炎。在接受替卡西林的72名高危患者中,只有26名(36%)受到感染。在低危患者中,接受预防治疗的54名患者中有10名(18.5%)发生了子宫内膜炎,接受安慰剂的60名患者中有24名(40%)发生了子宫内膜炎。替卡西林似乎能有效降低高危和低危患者剖宫产术后子宫内膜炎的发生率。分娩期间盆腔检查的次数是发生子宫内膜炎最重要的单一因素。